Fnu Aapjeet , Tiffany Tang , Yixiao Zhang , Aditya Gopalan , Satish Kallappagoudar , Jessica Pan , Fengfei Ma , Sunil S. Shah , Shannon Rivera , Anita Ping-wen Liu , Veronica Juan , Ren Liu
{"title":"Fragmentation of recombinant human interleukin-12 by matriptase in CHO cell culture","authors":"Fnu Aapjeet , Tiffany Tang , Yixiao Zhang , Aditya Gopalan , Satish Kallappagoudar , Jessica Pan , Fengfei Ma , Sunil S. Shah , Shannon Rivera , Anita Ping-wen Liu , Veronica Juan , Ren Liu","doi":"10.1016/j.jbiotec.2025.04.010","DOIUrl":null,"url":null,"abstract":"<div><div>During the development of a recombinant CHO cell line expressing human Interleukin-12 fused to human IgG1 Fc (rhIL-12), we observed a prominent proteolytic cleavage of the rhIL-12 in its p40 subunit between Lys260 and Arg261. Using class-specific protease inhibitors, we concluded that the serine hydrolase family was responsible for the clipping. To identify the specific serine proteases involved, we conducted transcriptomic and proteomic analyses and identified several potential candidates. By performing in-vitro enzyme digestion experiments with these proteases, we determined that matriptase was responsible for the observed p40 clipping. Further confirmation was obtained through the development of matriptase (S<em>t14</em>) knockout cell lines in which rhIL-12 clipping was almost completely abolished. Armed with this knowledge, we devised several strategies including increasing culture pH to reduce matriptase activity and rhIL-12 clipping during the manufacturing process.</div></div>","PeriodicalId":15153,"journal":{"name":"Journal of biotechnology","volume":"404 ","pages":"Pages 112-120"},"PeriodicalIF":4.1000,"publicationDate":"2025-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of biotechnology","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0168165625000963","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
During the development of a recombinant CHO cell line expressing human Interleukin-12 fused to human IgG1 Fc (rhIL-12), we observed a prominent proteolytic cleavage of the rhIL-12 in its p40 subunit between Lys260 and Arg261. Using class-specific protease inhibitors, we concluded that the serine hydrolase family was responsible for the clipping. To identify the specific serine proteases involved, we conducted transcriptomic and proteomic analyses and identified several potential candidates. By performing in-vitro enzyme digestion experiments with these proteases, we determined that matriptase was responsible for the observed p40 clipping. Further confirmation was obtained through the development of matriptase (St14) knockout cell lines in which rhIL-12 clipping was almost completely abolished. Armed with this knowledge, we devised several strategies including increasing culture pH to reduce matriptase activity and rhIL-12 clipping during the manufacturing process.
在表达人白细胞介素-12与人IgG1 Fc (rhIL-12)融合的重组CHO细胞系的发育过程中,我们观察到rhIL-12的p40亚基在Lys260和Arg261之间发生了明显的蛋白水解裂解。使用类特异性蛋白酶抑制剂,我们得出结论,丝氨酸水解酶家族负责剪切。为了确定所涉及的特定丝氨酸蛋白酶,我们进行了转录组学和蛋白质组学分析,并确定了几个潜在的候选酶。通过对这些蛋白酶进行体外酶消化实验,我们确定基质酶是观察到的p40剪切的原因。通过对基质酶(St14)敲除细胞系的研究,进一步证实了这一点,在这些细胞系中,rhIL-12几乎完全被切断。有了这些知识,我们设计了几种策略,包括增加培养pH来降低基质酶活性和在生产过程中切断rhIL-12。
期刊介绍:
The Journal of Biotechnology has an open access mirror journal, the Journal of Biotechnology: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review.
The Journal provides a medium for the rapid publication of both full-length articles and short communications on novel and innovative aspects of biotechnology. The Journal will accept papers ranging from genetic or molecular biological positions to those covering biochemical, chemical or bioprocess engineering aspects as well as computer application of new software concepts, provided that in each case the material is directly relevant to biotechnological systems. Papers presenting information of a multidisciplinary nature that would not be suitable for publication in a journal devoted to a single discipline, are particularly welcome.